Candice Jamois

7PUBLICATIONS
30CO-AUTHORS
Epidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 10, 2025
Enhancing Severe Neutropenia Prediction: PKPD-Informed Labeling for Machine Learning Models Trained on Real-World Data.

Conor J O'Hanlon, Jonas Denck, Elif Ozkirimli

|Jun 27, 2025
Tocilizumab Dosing for Management of T Cell-Engaging Bispecific Antibody-Related CRS in Patients With R/R B-Cell NHL.

Candice Jamois, David C Turner, Leonid Gibiansky

|Apr 18, 2025
Oncology Dose Optimization: Tailored Approaches to Different Molecular Classes.

Jiawen Zhu, Amy Schroeder, Sabine Frank

|Jul 13, 2024
Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre- and on-Treatment Prognostic Biomarkers.

Sébastien Benzekry, Mélanie Karlsen, Célestin Bigarré

|Dec 21, 2021
The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study.

John Mascarenhas, Francesco Passamonti, Kate Burbury

|May 04, 2019
Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab-refractory follicular lymphoma patients in the GADOLIN phase III study.

Ekaterina Gibiansky, Leonid Gibiansky, Vincent Buchheit

Pageof 2

Frequent Collaborators

1 joint publications

Jonathan C Strefford

1 joint publications

John Mascarenhas

1 joint publications

Francesco Passamonti

1 joint publications

Tarec Christoffer El-Galaly